Note 15. Equity Transactions

12 Months Ended

Jun. 30, 2013

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Note 15. Equity Transactions

(a) Stock Option Plan. The Company has adopted a stock option plan for the granting of options or restricted shares to employees, officers, directors and consultants of the Company that originally provided for the purchase of up to 7,000,000 shares of common stock, at the discretion of the Board of Directors. Subsequent to the adoption, the Board of Directors and stockholders approved additional common stock shares aggregating 6,000,000 to be available for grant, for a total of 13,000,000 shares of common stock reserved for issuance under the Company’s 2001 Stock Option Plan, as amended. Stock option grants may not be priced less than the fair market value of the Company’s common stock at the date of grant. Options granted are generally for ten-year periods, except that incentive stock options granted to a 10% stockholder (as defined) are limited to five-year terms.

The following options, warrants and potentially dilutive shares for convertible notes payable (see Note 8. Senior Credit Facility, Subordinated Convertible Note Payable, net - CD Financial, LLC and other Long Term Debt) were not included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for fiscal years ended June 30, 2013 and 2012:

	Fiscal Year Ended June 30,
	2013		2012
Anti-dilutive stock options		2,269,088		2,915,338
Anti-dilutive warrants		500,000		500,000
Anti-dilutive shares for convertible notes payable		8,230,769		8,230,769
Total anti-dilutive shares		10,999,857		11,646,107

During the fiscal year ended June 30, 2013 and 2012, the Company has incurred stock compensation expense of $0 and $10, respectively and is included in selling and administrative expenses in the consolidated statement of operations. Stock compensation expense includes Restricted Stock Units granted under the Company’s Stock Option Plan that are also expensed over the vesting period.

The intrinsic value of options outstanding and exercisable at June 30, 2013 and 2012 was $74 and none, respectively.

A summary of the Company’s stock option activity, and related information for the years ended June 30, follows:

	Options			Weighted Average Exercise Price
Outstanding as of July 1, 2011		3,016,338		$	5.42
Granted		-			-
Exercised		-			-
Terminated		(61,500	)		1.44
Expired		(39,500	)		2.79
Outstanding as of June 30, 2012		2,915,338			5.54
Granted		-			-
Exercised		-			-
Terminated		(24,000	)		0.75
Expired		(92,500	)		1.47
Outstanding as of June 30, 2013		2,798,838		$	5.72
Exercisable at June 30, 2012		2,915,338		$	5.54
Exercisable at June 30, 2013		2,798,838		$	5.72

The following table summarizes the range of exercise prices and weighted-average exercise prices for stock options outstanding and exercisable as of June 30, 2013 under the Company’s stock option plans:

Range of Exercise Price					Outstanding		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Exercisable		Weighted Average Exercise Price
$	0.14	-	$	0.15		629,750	$	0.14		5.3		629,750	$	0.14
$	2.96	-	$	2.96		50,000		2.96		4.8		50,000		2.96
$	3.05	-	$	3.05		183,600		3.05		4.4		183,600		3.05
$	3.13	-	$	3.13		50,000		3.13		2.4		50,000		3.13
$	3.86	-	$	4.10		72,000		3.97		2.4		72,000		3.97
$	5.29	-	$	6.93		931,170		6.38		1.6		931,170		6.38
$	7.48	-	$	7.90		26,500		7.88		1.9		26,500		7.74
$	9.90	-	$	10.89		845,818		10.01		0.4		845,818		10.01
$	14.90	-	$	14.90		10,000		14.90		0.8		10,000		14.90
$	0.14	-	$	14.90		2,798,838	$	5.72		2.5		2,798,838	$	5.72

(b) Warrants. As of June 30, 2013 and 2012, the Company has 500,000 warrants outstanding to purchase shares of common stock at $0.80. All warrants are currently exercisable and expire in October 2013.